Immunovant (IMVT) PT Lowered to $28 at Stifel, Model Update Following Earnings

February 16, 2021 10:29 AM EST
Get Alerts IMVT Hot Sheet
Price: $15.23 -1.23%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 20 | New: 68
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Stifel analyst Derek C. Archila lowered the price target on Immunovant (NASDAQ: IMVT) to $28.00 (from $33.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Stifel, Earnings